ABCL-353 Phase 1b Open-Label Study of Loncastuximab Tesirine in Combination with Other Anticancer Agents in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)
Clinical Lymphoma Myeloma and Leukemia（2024）
关键词
ABCL,non-Hodgkin lymphoma,loncastuximab tesirine,glofitamab,mosunetuzumab,phase 1,trial-in-progress
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要